Tilray | TRLY - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Acasti Pharma USD 1.96M 180K 2025-09
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
Aurora Cannabis CAD 41.4M 781K 2026-03
Avita Medical AUD 19.03M 1.95M 2025-12
Canopy Growth CAD 31.17M 2.27M 2026-03
Cronos Group USD 17.59M 237K 2026-06
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Moderna USD 216M 43M 2026-06
Organigram Holdings CAD 22.01M 14.28M 2026-03
Organon & Co USD 434M 10M 2026-06
Revvity USD 278.58M 24.69M 2026-06
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 1.13B 205.7M 2026-06
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03
Zealand Pharma A/S 104M 12.19M 2026-03